Amid the COVID-19 pandemic in India, a new threat has emerged – Mucormycosis or Black Fungus. This rare and severe fungal disease is affecting many individuals, especially those recovering from COVID-19, adding strain to the healthcare system. Increased awareness and preparedness are essential.
What Is Mucormycosis?
Mucormycosis, also known as Black Fungus, is a rare fungal infection caused by Mucormycetes mold. It affects the sinuses and areas around the eyes, especially in individuals with weakened immune systems. The infection becomes severe when the body can’t combat the fungus independently, leading to its spread.
Causes Of Black Fungus:
Exposure to Mucormycetes mold, commonly found in decaying organic matter, can cause Black Fungus. Inhalation of mold spores can lead to respiratory infection, and cuts or burns may result in skin exposure. Those with weakened immune systems, including surgery patients, individuals with diabetes, HIV/AIDS patients, organ transplant recipients, and cancer patients, are more susceptible to Mucormycosis.
Signs And Symptoms:
Mucormycosis can manifest as a skin or respiratory ailment. Sinus or respiratory infection symptoms include sinus discomfort, nasal congestion, headache, fever, and cough. Skin infections may present as prolonged ulcers, bleeding in the gastrointestinal tract, swelling near the face, black sores on the nose and mouth, intense abdominal pain, stool with blood, elevated fever, skin swelling, rashes, and blisters. Early detection and prompt medical attention are crucial if these symptoms are observed.
Is Mucormycosis Contagious?
Mucormycosis is not contagious and cannot be transmitted from person to person. Prevention involves self-care, especially for individuals with compromised immune systems. Wearing masks during gardening and proper wound care can reduce the risk of fungal infections. Additional precautions are recommended during the summer and fall when the fungus is more prevalent.
Treatment:
The primary treatments for Mucormycosis include intravenous antifungal medications and surgical debridement to remove contaminated tissue. Successful treatment may involve switching from intravenous to oral medication after initial therapy. Antifungal medications such as Posaconazole, Amphotericin, and Isavuconazole are commonly prescribed. Recovery from Mucormycosis depends on early diagnosis and treatment, with a risk of demise in severe cases.
Diagnosis:
Many individuals with Mucormycosis may not be aware of their condition, and diagnosis often occurs during consultations for skin, sinus, or lung infections. Tissue samples, such as nasal discharge or phlegm, are examined in a lab to confirm the diagnosis. Early detection is vital for effective treatment.
Additionally, securing comprehensive health insurance, such as critical illness plans, ensures financial support for the high costs associated with Mucormycosis treatment. Awareness of the symptoms and seeking timely medical care are crucial in combating this emerging health threat. Health insurance provides essential coverage, offering financial security and peace of mind in times of unexpected health challenges, such as the rising cases of Mucormycosis. Having critical illness insurance is a prudent decision, offering financial support and reassurance in the face of severe health conditions like Mucormycosis. Claims are subject to terms and conditions set forth under the health insurance policy. *
Exploring diverse health insurance plans for family coverage is essential to guarantee comprehensive protection and peace of mind for all members in times of health uncertainties. You can utilise a health insurance premium calculator to estimate the costs of premiums to be paid. Claims are subject to terms and conditions set forth under the health insurance policy.
*Standard T&C Apply
Insurance is the subject matter of solicitation. For more details on benefits, exclusions, limitations, terms, and conditions, please read the sales brochure/policy wording carefully before concluding a sale.
